microINR for anticoagulation therapy

Equality considerations

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination, and fostering good relations between people with particular protected characteristics and others.

Older people, people from south Asian groups and people who are male are all disproportionately affected by heart disease. Age, race and sex are all protected characteristics under the Equality Act 2010.

Access to the device may be of particular benefit to groups having long‑term vitamin K antagonist therapy, such as adults in work or education, adults with disabilities or older people, who may find travel to clinics for international normalised ratio (INR) testing difficult or demanding. Users must be physically and cognitively able to self-test accurately.